bisnafide has been researched along with naphthalimides in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gale, KC; Hsiung, Y; Nitiss, JL; Osheroff, N; Rose, A; Zhou, J | 1 |
| Ghaneolhosseini, H; Sjöberg, S | 1 |
2 other study(ies) available for bisnafide and naphthalimides
| Article | Year |
|---|---|
The bis(naphthalimide) DMP-840 causes cytotoxicity by its action against eukaryotic topoisomerase II.
Topics: Adenine; Alleles; Antineoplastic Agents; DNA Topoisomerases, Type II; Drug Resistance, Microbial; Humans; Imides; Isoquinolines; Mesylates; Naphthalimides; Organophosphonates; Saccharomyces cerevisiae | 1998 |
Synthesis of a boronated naphthalimide for potential use in boron neutron capture therapy (BNCT).
Topics: 1-Naphthylamine; Boron Compounds; Boron Neutron Capture Therapy; DNA; Imides; Intercalating Agents; Isoquinolines; Mesylates; Models, Chemical; Naphthalimides; Solubility; Spermidine; Water | 1999 |